JP2018072313A5 - - Google Patents

Download PDF

Info

Publication number
JP2018072313A5
JP2018072313A5 JP2017080646A JP2017080646A JP2018072313A5 JP 2018072313 A5 JP2018072313 A5 JP 2018072313A5 JP 2017080646 A JP2017080646 A JP 2017080646A JP 2017080646 A JP2017080646 A JP 2017080646A JP 2018072313 A5 JP2018072313 A5 JP 2018072313A5
Authority
JP
Japan
Prior art keywords
gapdh
level
sample
subject
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017080646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018072313A (ja
JP6611753B2 (ja
Filing date
Publication date
Priority claimed from US15/335,036 external-priority patent/US11193933B2/en
Application filed filed Critical
Publication of JP2018072313A publication Critical patent/JP2018072313A/ja
Publication of JP2018072313A5 publication Critical patent/JP2018072313A5/ja
Application granted granted Critical
Publication of JP6611753B2 publication Critical patent/JP6611753B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017080646A 2016-10-26 2017-04-14 アルツハイマー病の診断方法 Active JP6611753B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/335,036 US11193933B2 (en) 2016-10-26 2016-10-26 Measuring GAPDH protein for diagnosis and treatment of alzheimer's disease
US15/335,036 2016-10-26

Publications (3)

Publication Number Publication Date
JP2018072313A JP2018072313A (ja) 2018-05-10
JP2018072313A5 true JP2018072313A5 (enExample) 2018-06-21
JP6611753B2 JP6611753B2 (ja) 2019-11-27

Family

ID=61969495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017080646A Active JP6611753B2 (ja) 2016-10-26 2017-04-14 アルツハイマー病の診断方法

Country Status (3)

Country Link
US (1) US11193933B2 (enExample)
JP (1) JP6611753B2 (enExample)
CN (1) CN107991490B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111198270B (zh) * 2018-11-16 2023-04-07 山东泽济生物科技有限公司 一种用于甘油醛-3-磷酸脱氢酶磁微粒化学发光检测试剂盒及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000022156A1 (en) * 1998-10-13 2000-04-20 Ono Pharmaceutical Co., Ltd. Antibody against glycerylaldehyde-3-phosphate dehydrogenase and utilization thereof
US20020172676A1 (en) 2001-05-16 2002-11-21 George Jackowski Method of treatment of alzheimer's disease and device therefor
US20040265849A1 (en) 2002-11-22 2004-12-30 Applera Corporation Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereof
JP2005132738A (ja) * 2003-10-28 2005-05-26 Protein Express:Kk アルツハイマー病のタンパク質分子レベルにおける検出方法
AU2005274788A1 (en) * 2004-07-19 2006-02-23 University Of Rochester Biomarkers of neurodegenerative disease
DE102004052889A1 (de) * 2004-11-02 2006-05-11 Ruprecht-Karls-Universität Heidelberg Screeningverfahren zur Früherkennung des zerebralen Vasospasmus

Similar Documents

Publication Publication Date Title
Naylor et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh
Gurka et al. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score
Jang et al. Carrier frequency of Wilson’s disease in the Korean population: a DNA-based approach
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
CA2863393C (en) A multi-biomarker-based outcome risk stratification model for pediatric septic shock
JP2018509934A5 (enExample)
JP2020514689A5 (enExample)
CN106755522B (zh) 一种用于幼年型骨质疏松症检测的试剂盒
JP2009501333A5 (enExample)
JP2017504011A5 (enExample)
Smits et al. An expert panel‐based study on recognition of gastro‐esophageal reflux in difficult esophageal pH‐impedance tracings
Muhsen et al. Prevalence and determinants of serological evidence of atrophic gastritis among Arab and Jewish residents of Jerusalem: a cross-sectional study
CN105705652A (zh) 协助鉴别诊断中风的方法
JP2014512014A5 (enExample)
Reiner et al. The clock drawing test: A reasonable instrument to assess probable dementia in primary care?
Quade et al. Cortisol in deciduous tooth tissues: A potential metric for assessing stress exposure in archaeological and living populations
Bing et al. Evolution of sarcopenia status and risk of incident cardiovascular disease
RU2008103988A (ru) Способ диагностики рассеяного склероза
Lidbury et al. Evaluation of hyaluronic acid, procollagen type III N-terminal peptide, and tissue inhibitor of matrix metalloproteinase-1 as serum markers of canine hepatic fibrosis
JP2018072313A5 (enExample)
Shin et al. What is the appropriate cut-off value of CRP to predict endoscopic remission in patients with ulcerative colitis in clinical remission?
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
TWI507412B (zh) Gastric cancer biological markers and their use, as well as gastric cancer-related detection methods
US20170316176A1 (en) Device for analyzing insulin secretion ability, system for analyzing insulin secretion ability provided with same, and method for analyzing insulin secretion ability
JP2016526908A5 (enExample)